11:56 AM EDT, 07/09/2024 (MT Newswires) -- CNS Pharmaceuticals ( CNSP ) said Tuesday it has regained compliance with the Nasdaq Stock Market's minimum bid price requirement for continued listing.

The company regained compliance after the closing bid price of its common stock was at $1 per share or greater for the 20 consecutive business days through July 3, according to a filing with the US Securities and Exchange Commission.

CNS Pharmaceuticals ( CNSP ) shares were down 8.2% in recent trading.

Price: 1.07, Change: -0.10, Percent Change: -8.19